RUNX2 and myeloid sarcoma: Nevertheless, in our study, the lower ECM contentin cartilage-like in vitro models following MS correlatedwith increased FGF-2 release and upregulation of RUNX2 and ADAMTS5, suggesting their involvement in ECMdegradation.